| Metric | შპს ნიუ ფარმ გრუპი | შპს ნიუ ფარმა | შპს ნიუ ფარმა NEW PHARMA |
|---|---|---|---|
| Growth | |||
| Revenue | ₾4.6m₾9.9m | ₾21.9m₾18.3m | ₾883₾4.1m |
| Revenue growth | -53.2% | 19.6% | -100.0% |
| Profitability | |||
| EBITDA | ₾1.1m₾2.8m | ₾3.5m₾5.3m | -₾262k-₾476k |
| EBITDA margin | 24.1%27.8% | 15.8%29.2% | -29687.2%-11.6% |
| Net profit | ₾712k₾2.5m | ₾2.1m | |
| -₾258k-₾726k |
| Net margin | 15.3%24.9% | 9.7%24.9% | -29249.2%-17.7% |
| Balance sheet | |||
| Total assets | ₾3.3m₾5.0m | ₾10.9m₾13.2m | ₾83k₾1.4m |
| Total equity | ₾362k₾1.9m | ₾5.9m₾5.5m | -₾780k-₾522k |
| ROE | 196.7%126.8% | 36.1%82.8% | — |